• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Brooks Laboratories Ltd

+ Add to Watchlist

BKL:IN

43.40 INR 2.00 4.41%

As of 07:05:46 ET on 08/01/2014.

Snapshot for Brooks Laboratories Ltd (BKL)

Open: 44.25 Day's Range: 42.85 - 47.10 Volume: 882,424
Previous Close: 45.40 52wk Range: 13.15 - 48.00 1-Yr Rtn: +198.28%

Stock Chart for BKL

No chart data available.
  • BKL:IN 43.40
  • 1D
  • 1M
  • 1Y
45.40
Interactive BKL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BKL

Current P/E Ratio (ttm) 7.9504
Estimated P/E(-) -
Relative P/E vs. SENSEX 0.4399
Earnings Per Share (ttm) 5.4588
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 702.49
Shares Outstanding (M) 16.19
30 Day Average Volume 590,894
Price/Book (mrq) 0.7697
Price/Sale (ttm) 0.8240
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BKL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for BKL

Brooks Laboratories Limited is a research and development driven pharmaceutical manufacturing company. The Company is a contract manufacturing company for the latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Atul RanchalChairman/Executive DirectorRajesh MahajanManaging Director/Co-Founder
Durga Sankar MaityCEO/Executive DirectorKetan ShahChief Financial Officer
More Company Profile & Key Executives for BKL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil